Wnt5a expression is downregulated via aberrant methylation in most acute leukemia cases, and is upregulated in non-malignant hematopoietic (NMH) and complete remission (CR) cases; thus, increased Wnt5a expression might act as a tumor suppressor in leukemia [53–56]. The gene discussed is WNT5A; the disease is neoplasm.